Zimmer Biomet Holdings (ZBH) Cash from Investing Activities Growth (3y) (2012 - 2026)
Zimmer Biomet Holdings (ZBH) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -253.01% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -11.91% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -41.67% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -6.88% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -472.46% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -16.93% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -111.03% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -40.94% |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | -2.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.10% |
| Dec 31, 2025 | -41.98% |
| Sep 30, 2025 | -24.22% |
| Jun 30, 2025 | -78.55% |
| Mar 31, 2025 | -9.34% |
| Dec 31, 2024 | -32.92% |
| Sep 30, 2024 | -11.32% |
| Jun 30, 2024 | -35.68% |
| Mar 31, 2024 | -21.73% |
| Dec 31, 2023 | 6.07% |
| Sep 30, 2023 | -21.91% |
| Jun 30, 2023 | -41.78% |
| Mar 31, 2023 | -7.22% |
| Dec 31, 2022 | 6.58% |
| Sep 30, 2022 | 19.55% |
| Jun 30, 2022 | 8.95% |
| Mar 31, 2022 | 8.39% |
| Dec 31, 2021 | -14.59% |
| Sep 30, 2021 | 6.84% |
| Jun 30, 2021 | -1.85% |